Link to the annual harvest lecture delivered live online
On February 12, the eighth harvest lecture will be held at the Davidson Institute and will be broadcast live on the Internet. Last year it was the winner of the Nobel Prize in Chemistry Prof. Ada Yonat and this year the President of the National Academy of Sciences and Arts Prof. Ruth Arnon, also from the Weizmann Institute, will speak.
Summary of the lecture:
The existing vaccine components are mostly based on the cause of the disease (bacterium or virus) when it is killed or weakened, so that it is not able to cause the disease but is effective in providing a vaccine against it. By using the ingredient, the morbidity is prevented. Over the years, these ingredients have led to the extinction of a number of deadly diseases and epidemics such as smallpox or polio, thus contributing more than anything to public medicine.
The next challenges are first of all dealing with new or emerging diseases, such as AIDS or tuberculosis, and developing effective vaccine components against them. Another challenge is viruses that undergo frequent mutations, such as the influenza virus, which to deal with requires a new vaccine composition every year. The challenge is to develop a "universal" component that will protect against a large number of virus strains. Another challenge of first-class importance is the development of medicinal ingredients, with the help of which it will be possible to treat diseases after their appearance and not only for the time being. This approach is particularly important for diseases such as cancer or autoimmune diseases, for which prophylactic vaccination is not a practical solution. Research approaches to the development of innovative vaccine components present a chance for further achievements in broad sectors of public medicine.
The lecture can be seen live on the website of the Davidson Institute for Science Education
The lecture will be held in the Wix Hall - the Weizman Institute for Rehovot Science, and will be broadcast live to a number of schools across the country.
Participation is free of charge, but pre-registration is required.
The annual harvest lecture is held with the support of Dr. Gil Oman and Marta Darling from the USA.
Go to the page on the Davidson Institute website for updates on the broadcasts of the lecture
2 תגובות
Antivirus companies make a lot of money from viruses that exist…
The more viruses there are, the better for them, there is work
They will push you products that will also slow down your computer... the main thing is to be protected!!!
Babies today who receive vaccines, for some it is difficult...the baby gets sick. I'm not talking about studies, I'm talking about life experience. These babies who get sick, for some it gets complicated and it puts a strain on the body's systems. That's why many, especially parents, are afraid of vaccines.
Today vaccines are a moving film, there is no examination of how the child reacted to the vaccine.
The economic model used today simply asks these companies to generate as much work as possible for themselves. This is how it is in every field...
This is a program that conveys the situation simply
http://www.youtube.com/watch?v=FoHhwl27Hs4&feature=related
If the economic model were to encourage unemployment, that is, if they create a vaccine that includes everything... create products that last as long as possible. Or if there is a device for sale, you pay for usage time and not for the device itself. (Assume a very small payment for many years)
The ambition of the companies was that you would use the devices as much as possible for as long as possible.
The ambition was to produce devices that do not break down. And even a better repair service.
Let's think together - the pharmaceutical company's considerations regarding the universal flu vaccine:
The lofty goal: "Another challenge is viruses that undergo frequent mutations, such as the flu virus, which in order to deal with it, a new vaccine is needed every year. The challenge is to develop a "universal" component that will protect against a large number of strains of the virus."
Revaccinate every year all those who want to be vaccinated (I have no idea how much it costs) for n years when n > 10 at least.
***or***
Development of a universal vaccine that will protect against many strains of influenza with the goal that every person will be vaccinated once or a little more
Well... Follow the money...
Hmmm... the chairman of the pharmaceutical company's board of directors scratched his chin - it will only pay off if we develop new and updated viruses that this vaccine won't catch... and the fryers will still have to pay for additions and version updates...